This proposal seeks support for cross-national comparative analyses of data in a number of existing epidemiologic surveys on patterns, predictors, and consequences of substance use and substance use disorders. All the surveys are based on general population samples and use the recently developed WHO Composite International Diagnostic Interview (CIDI) to assess DSM-III-R substance use disorders. The four surveys to be analyzed in YRS 1-3 include a US national survey, a province-wide survey of Ontario, a survey of Mexicans and Mexican- Americans in California, and a survey of the Mexico City metropolitan area. A total of approximately 25,000 respondents are included in these four surveys. Additional surveys to be added in YRS 4-5 will include all those carried out in general population samples in any country in the world as of the time data analysis begins. This currently includes 18 surveys in 13 countries with a total sample of over 73,000 respondents. Millions of dollars have been and are being invested in these data collections. Yet there is currently no coordinated effort to combine the results into an analysis of world substance use disorders. This is the goal of the current proposal, which aims to: (l) assemble a merged dataset made up from all the above surveys; (2) replicate and expand analyses previously carried out by the PI and his collaborators in the National Comorbidity Survey on patterns and predictors of substance use and substance use disorders; (3) produce data documenting the enormous adverse social consequences of substance use disorders for those who suffer from them and their communities; and (4) export the skills required to carry out these types of analyses to the collaborators in 13 countries around the world. The proposed work is highly significant both for the advancement of our knowledge of the descriptive and analytic epidemiology of substance use disorders and for the social policy goal of increasing international awareness of these disorders as a major public health problem around the world.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA011121-03
Application #
2770156
Study Section
Human Development Research Subcommittee (NIDA)
Program Officer
Obrien, Moira
Project Start
1996-09-30
Project End
2001-08-31
Budget Start
1998-09-01
Budget End
1999-08-31
Support Year
3
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Harvard University
Department
Administration
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Kessler, R C; Borges, G; Sampson, N et al. (2009) The association between smoking and subsequent suicide-related outcomes in the National Comorbidity Survey panel sample. Mol Psychiatry 14:1132-42
Glantz, M D; Anthony, J C; Berglund, P A et al. (2009) Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits. Psychol Med 39:1365-77
Karam, Elie G; Mneimneh, Zeina N; Karam, Aimee N et al. (2006) Prevalence and treatment of mental disorders in Lebanon: a national epidemiological survey. Lancet 367:1000-6
Caraveo-Anduaga, Jorge J; Nicolini-Sanchez, Humberto; Villa-Romero, Antonio et al. (2005) [Psychopathology across three family generations: an epidemiological study in Mexico City] Salud Publica Mex 47:23-9
Zimmermann, P; Wittchen, H U; Hofler, M et al. (2003) Primary anxiety disorders and the development of subsequent alcohol use disorders: a 4-year community study of adolescents and young adults. Psychol Med 33:1211-22
Andrade, Laura; Caraveo-Anduaga, Jorge J; Berglund, Patricia et al. (2003) The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys. Int J Methods Psychiatr Res 12:3-21
Bijl, Rob V; de Graaf, Ron; Hiripi, Eva et al. (2003) The prevalence of treated and untreated mental disorders in five countries. Health Aff (Millwood) 22:122-33
Kessler, R C; Andrade, L H; Bijl, R V et al. (2002) The effects of co-morbidity on the onset and persistence of generalized anxiety disorder in the ICPE surveys. International Consortium in Psychiatric Epidemiology. Psychol Med 32:1213-25
Vega, William A; Aguilar-Gaxiola, Sergio; Andrade, Laura et al. (2002) Prevalence and age of onset for drug use in seven international sites: results from the international consortium of psychiatric epidemiology. Drug Alcohol Depend 68:285-97
Kessler, R C; Aguilar-Gaxiola, S; Berglund, P A et al. (2001) Patterns and predictors of treatment seeking after onset of a substance use disorder. Arch Gen Psychiatry 58:1065-71

Showing the most recent 10 out of 14 publications